2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Adrenal Gland Cancer
Exploring the intricacies of adrenal gland cancer stands as a beacon in oncological research, despite its rarity. Nestled atop the kidneys, these glands wield immense influence over hormonal balance, making them prime targets for malignancy. Unraveling the genetic tapestry driving these tumors forms the cornerstone of tailored treatment modalities. From the pursuit of novel biomarkers for early detection to the fine-tuning of immunotherapeutic and targeted interventions, the landscape of adrenal cancer research is dynamic. Innovations in imaging techniques further illuminate pathways for precise diagnosis and monitoring. Through interdisciplinary collaborations and relentless pursuit of breakthroughs, the collective effort converges towards a brighter horizon, offering renewed hope for patients grappling with adrenal gland cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China